Japan Issues Development List For Unapproved Indications; Kyowa Hakko, BMS And Sanofi Lead Requests
This article was originally published in PharmAsia News
Executive Summary
MHLW solicited requests from medical associations for compounds with unapproved indications in Japan that would meet unmet medical needs.